Memantine discontinuation and the health status of nursing home residents with Alzheimer's disease.
Fillit
Howard
H
Brookdale Department of Geriatrics and Adult Development, The Mount Sinai School of Medicine, New York, NY, USA. hfillit@alzdiscovery.org
Hofbauer
Robert K
RK
Setyawan
Juliana
J
Tourkodimitris
Stavros
S
Fridman
Moshe
M
Pejović
Vojislav
V
Miller
Michael L
ML
Erder
M Haim
MH
Lyketsos
Constantine
C
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000503:physiopathology; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D006304:Health Status; D006801:Humans; D008485:Medical Audit; D008559:Memantine / Q000627:therapeutic use*; D009735:Nursing Homes; D012189:Retrospective Studies; D014481:United States; D028761:Withholding Treatment
D000978:Antiparkinson Agents; D008559:Memantine